Analysis on the Development Trend and Countermeasures of Clopidogrel

摘要/Abstract

摘要：

Objective To analyze the development trend of clopidogrel bisulfate so as to provide suggestions for the research and development (R&D) of China’s pharmaceutical enterprises. Methods By studying the development process of thiophenic pyridine drugs, we found that clopidogrel bisulfate belongs to the second generation product. Then, the patent status of generic drugs of thiophene in the United States and China was analyzed to identify the key points and trends of its R&D. Results and Conclusion This paper analyzes the patent and important technology of clopidogrel to predict its development trend, and put forward countermeasures for Chinese pharmaceutical enterprises.

关键词:

clopidogrel bisulfate, patent, development trend

Abstract:

Key words:

clopidogrel bisulfate, patent, development trend

Wu Tong, Dong Li. Analysis on the Development Trend and Countermeasures of Clopidogrel [J]. 亚洲社会药学, 2021, 16(2): 139-144.

Wu Tong, Dong Li. Analysis on the Development Trend and Countermeasures of Clopidogrel [J]. Asian Journal of Social Pharmacy, 2021, 16(2): 139-144.

[1]	Yuan Hongmei, Zhang Wenfeng, Ma Junhong, Zeng Yingying, Meng Lingquan. Research on the Identification of Core Technologies of China’s Pharmaceutical Cold Chain Based on Patent Analysis[J]. 亚洲社会药学, 2021, 16(2): 128-138.
[2]	Ma Junhong, Zhang Wenfeng, Liu Yue, Yuan Hongmei, Zhang Dawei. Research on the Status Quo and Countermeasures of Patent Application in Liaoning Biopharmaceutical Industry Based on Patent Map[J]. 亚洲社会药学, 2021, 16(2): 145-153.
[3]	Wang Hongwei, Yang Yue. Research and Reference of the Authorized Generic Drug System in the US[J]. 亚洲社会药学, 2021, 16(1): 11-22.
[4]	Zhang Tianqi, Chen Yuwen. Research on the World’s Most Valuable Antihypertensive Drugs Based on Patent Analysis[J]. 亚洲社会药学, 2021, 16(1): 76-83.
[5]	Nie Zewen, Wang Ting, Yuan Hongmei. Analysis of Technological Opportunities in Liaoning Biopharmaceutical Industry from the Perspective of Innovation Subject[J]. 亚洲社会药学, 2020, 15(3): 126-138.
[6]	Zhang Wenfeng, Feng Xin, Yuan Hongmei. Research on Technology Opportunity Identification of Small and Medium-sized Vaccine Enterprises Based on Patent Analysis[J]. 亚洲社会药学, 2020, 15(2): 97-107.
[7]	Wu Yakun, Yuan Hongmei. Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data[J]. 亚洲社会药学, 2019, 14(4): 174-184.
[8]	Zhao Zhe, Sheng Mengdi, Fan Junyan, Liu Yanwen, Dong Li. Patent Applications of Pharmaceutical Industry in Liaoning: Current Situation and Suggestions[J]. 亚洲社会药学, 2019, 14(4): 185-191.
[9]	Huang Yufeng, Luo Suping, Yuan Hongmei. Research on Drug-Patent Linkage System under the New Situation[J]. 亚洲社会药学, 2019, 14(1): 7-14.
[10]	Ding Wenqing, Luo Suping, Yuan Hongmei, Zhang Dawei. Research on Protection of the Interests of Generic Drug Companies in the Drug-Patent Linkage System Based on Cournot Model [J]. 亚洲社会药学, 2019, 14(1): 15-20.
[11]	Jin Quanyuan, Lin Xiaohui, Dong Li. Patent Early Warning Mechanism in Pharmaceutical Universities in China[J]. 亚洲社会药学, 2018, 13(3): 86-92.
[12]	Jin Quanyuan, Lin Xiaohui, Dong Li. Research on Setting up Patent Risk Management System in Medical colleges and universities in China[J]. 亚洲社会药学, 2018, 13(1): 8-15.
[13]	DING Lei;WEI Ying;CHEN Yan;YUAN Hong-mei*. Analysis of TCM Patented Technology Based onthe IPC Classification System[J]. , 2015, 10(4): 197-202.
[14]	LI Jun-li;WEN Qi;YU Pei-ming. Patent Status of Antidepressants: Duloxetine[J]. , 2014, 9(2): 87-91.
[15]	DONG Li;HUANG Tai-kang;;FU Ke-ling. Pharmaceutical Enterprises in China: Patent Infringement Risks and Management Strategies[J]. , 2014, 9(1): 22-24.

亚洲社会药学